User login

As WTO members eye expanding TRIPS decision, U.S. treads carefully

July 27, 2022 at 5:42 PM
As lawmakers and industry groups increase pressure against the push at the World Trade Organization to expand a recent intellectual property decision to include diagnostics and therapeutics, the Biden administration has kept a low profile, declining to say publicly where it stands -- but its past positions and a recent statement suggest no eagerness to move forward on the issue. WTO members during the 12th ministerial conference last month agreed to further flexibilities under the Agreement on Trade-Related Aspects of...


Not a subscriber? Sign up for 30 days free access to exclusive, behind-the-scenes reporting on trade policy in the Biden era.